Page last updated: 2024-09-04

ezetimibe and bay 58-2667

ezetimibe has been researched along with bay 58-2667 in 1 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(bay 58-2667)
Trials
(bay 58-2667)
Recent Studies (post-2010) (bay 58-2667)
2,4845631,465104669

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, P; Jia, A; Jiang, H; Liu, W; Sun, J; Xu, Q; Zhang, R1

Other Studies

1 other study(ies) available for ezetimibe and bay 58-2667

ArticleYear
Novel application potential of cinaciguat in the treatment of mixed hyperlipidemia through targeting PTL/NPC1L1 and alleviating intestinal microbiota dysbiosis and metabolic disorders.
    Pharmacological research, 2023, Volume: 194

    Topics: Cholesterol; Dysbiosis; Ezetimibe; Gastrointestinal Microbiome; Humans; Hyperlipidemias; Lipase; Lipidoses; Membrane Transport Proteins; Triglycerides

2023